Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02300935
Title Study of Trametinib and Nab-paclitaxel in Patients With Melanoma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications

melanoma

Therapies

Nab-paclitaxel + Trametinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.